Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Prostaglandin E3 (PGE3) is formed via the cyclooxygenase (COX) metabolism of eicosapentaenoic acid (EPA; Item Nos. 90110 | 90110.1 | 21908).1 In human ocular tissue, it comprises 2.4% of the COX products formed.1 When applied to the eyes of a rabbit, a 1 µg dose of PGE3 decreases intraocular pressure from 21 mmHg to about 17 mmHg.2
WARNING This product is not for human or veterinary use.
1. Eicosapentaenoic acid metabolism in human and rabbit anterior uvea. Prostaglandins 31(6), 1159-1164 (1986).
2. Prostaglandins E3 and D3 lower intraocular pressure. Invest. Ophthalmol. Vis. Sci. 26(8), 1178-1182 (1985).
Analytical strategy for oxylipin annotation by combining chemical derivatization-
Quantitative profiling of inflammatory and pro-
Lipid storm within the lungs of severe COVID-
Apolipoprotein A-
Omega-
Determination of ω-